Association between low concentrations of antibodies to protein α and Rib and invasive neonatal group B streptococcal infection

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 91, Issue 6, 2006, Pages

  Larsson, C ^a,b   Lindroth, M ^c   Nordin, P ^d   Stalhammar Carlemalm M ^b   Lindahl, G ^b   Krantz, I ^d,e  

^a UDDEVALLA HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d Skaraborgs Institutet   (Sweden)

^e UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; IMMUNOGLOBULIN G ANTIBODY; PROTEIN RIB; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL STRAIN; BLOOD DONOR; BLOOD PH; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INFANT; MALE; PLACENTAL TRANSFER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMANS; IMMUNOGLOBULIN G; INFANT, NEWBORN; MEMBRANE PROTEINS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 33750799583     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2005.090472     Document Type: Article

References (34)

1. Källman J, Kihlström E, Sjöberg L, et al. Increase of staphylococci in neonatal septicaemia: a fourteen-year study. Acta Paediatr 1997;86:533-8.
2. Aavitsland P, Hoiby EA, Lystad A. Systemic group B streptococcal disease in neonates and young infants in Norway 1985-94. Acta Paediatr 1996;85:104-5.
3. Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15-20.
4. Persson E, Trollfors B, Brandberg LL, et al. Septicaemia and meningitis in neonates and during early infancy in the Göteborg area of Sweden. Acta Paediatr 2002;91:1087-92.
5. Trijbels-Smeulders M, Gerards LJ, M PC, et al. Epidemiology of neonatal group B streptococcal disease in The Netherlands 1997-98. Paediatr Perinat Epidemiol 2002;16:334-41.
6. Persson K, Bjerre B, Elfström L, et al. Longitudinal study of group B streptococcal carriage during late pregnancy. Scand J Infect Dis 1987;19:325-9.
7. Yancey MK, Schuchat A, Brown LK, et al. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996;88:811-15.
8. Edwards MS, Baker CJ. Group B streptococcal infections. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. Philadelphia: WB Saunders Company, 2001:1091-156.
9. Bevanger L. The Ibc proteins of group B streptococci: isolation of the alpha and beta antigens by immunosorbent chromatography and test for human serum antibodies against the two antigens. Acta Pathol Microbiol Immunol Scand B 1985;93:113-19.
10. Lancefield RC, McCarty M, Everly WN. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J Exp Med 1975;142:165-79.
11. Michel JL, Madoff LC, Kling DE, et al. Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity. Infect Immun 1991;59:2023-8.
12. Stålhammar-Carlemalm M, Stenberg L, Lindahl G. Protein Rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J Exp Med 1993;177:1593-603.
13. Larsson C, Stålhammar-Carlemalm M, Lindahl G. Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and α. Infect Immun 1996;64:3518-23.
14. Johnson DR, Ferrieri P. Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes. J Clin Microbiol 1984;19:506-10.
15. Larsson C, Stålhammar-Carlemalm M, Lindahl G. Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine. Vaccine 1999;17:454-8.
16. Michel JL, Madoff LC, Olson K, et al. Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci. Proc Natl Acad Sci USA 1992;89:10060-4.
17. Wästfelt M, Stålhammar-Carlemalm M, Delisse AM, et al. Identification of a family of streptococcal surface proteins with extremely repetitive structure. J Biol Chem 1996;271:18892-7.
18. Lindahl G, Stålhammar-Carlemalm M, Areschoug T. Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev 2005;18:102-27.
19. Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976;294:753-6.
20. Baker CJ, Edwards MS, Kasper DL. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics 1981;68:544-9.
21. Christensen KK, Christensen P, Lindberg A, et al. Mothers of infants with neonatal group B streptococcal septicemia are poor responders to bacterial carbohydrate antigens. Int Arch Allergy Appl Immunol 1982;67:7-12.
22. Lin FY, Weisman LE, Azimi PH, et al. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. J Infect Dis 2004;190:928-34.
23. Flores AE, Nelson JA, Wu XY, et al. Antibody profiles to the group B streptococcal beta antigen in maternal and infant paired sera. Acta Pathol Microbiol Immunol Scand B 1993;101:41-9.
24. Christensen KK, Christensen P, Duc G, et al. Human IgG antibodies to carbohydrate and protein antigens in mouse protection tests with group B streptococci. Pediatr Res 1984;18:478-82.
25. Kim KS, Wass CA, Hong JK, et al. Demonstration of opsonic and protective activity of human cord sera against type III group B streptococcus that are independent of type-specific antibody. Pediatr Res 1988;24:628-32.
26. Linden V, Christensen KK, Christensen P. Correlation between low levels of maternal IgG antibodies to R protein and neonatal septicemia with group B streptococci carrying R protein. Int Arch Allergy Appl Immunol 1983;71:168-72.
27. Lachenauer CS, Baker CJ, Baron MJ, et al. Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum. J Infect Dis 2002;185:368-74.
28. Stȧlhommar-Carlemalm M, Areschoug T, Larsson C, et al. The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells. Mol Microbiol 1999;33:208-19.
29. Lachenauer CS, Creti R, Michel JL, et al. Mosaicism in the alpha-like protein genes of group B streptococci. Proc Natl Acad Sci USA 2000;97:9630-5.
30. Stȧlhommar-Carlemalm M, Areschoug T, Larsson C, et al. Cross-protection between group A and group B streptococci due to cross-reacting surface proteins. J Infect Dis 2000;182:142-9.
31. Carpenter A. Enzyme-linked immunoassays. In: NR Rose HF, Fahey JL, eds. Manual of clinical laboratory immunology 4th ed. Washington DC: ASM Press, 1992.
32. Areschoug T, Stȧlhammar-Carlemalm M, Larsson C, et al. Group B streptococcal surface proteins as targets for protective antibodies: identification of two novel proteins in strains of serotype V. Infect Immun 1999;67:6350-7.
33. Bevanger L. Ibc proteins as serotype markers of group B streptococci. Acta Pathol Microbiol Immunol Scand B 1983;91:231-4.
34. Ailus KT. A follow-up study of immunoglobulin levels and autoantibodies in an unselected pregnant population. Am J Reprod Immunol 1994;31:189-96.